Skin itches when specialized nerve endings in your skin detect a chemical, physical, or electrical signal and relay it to your brain as an urge to scratch. The triggers range from a mosquito bite to kidney disease to dry winter air, but they all converge on the same basic wiring. Nearly 40% of people worldwide report experiencing itch in any given week, making it one of the most common sensations the body produces.
How Your Skin Detects an Itch
Your skin is threaded with tiny nerve fibers called pruriceptors, which act like antennae constantly sampling the skin’s environment. Most itch signals travel along slow-conducting C-fibers, the same thin nerve fibers involved in dull pain and temperature sensing. When these fibers pick up an itch-triggering substance, they fire electrical signals up through the spinal cord and into the brain, where the sensation registers as that familiar, irresistible urge to scratch.
Different types of itch travel along different fibers. Histamine, the chemical most people associate with itching, activates a specific subset of C-fibers that don’t respond to touch or pressure. Other itch triggers, like the tiny spines on cowhage (a tropical plant used in itch research), activate a completely separate set of fibers that do respond to mechanical contact. This is one reason antihistamines relieve some itches but do nothing for others.
Histamine: The Classic Itch Chemical
Mast cells are immune cells scattered throughout your skin, packed with preformed pouches of histamine, enzymes, and inflammatory molecules. When something triggers them (an allergen landing on your skin, a bug bite, physical pressure), they burst open in a process called degranulation, flooding the surrounding tissue with histamine. Histamine then locks onto receptors on nearby itch-sensing nerve fibers, firing off the signal that makes you scratch.
This is the pathway behind hives, many allergic reactions, and the red, raised welts you get from insect bites. It’s also why over-the-counter antihistamines work well for these types of itch. But histamine is only one player in a much larger cast.
Itch That Antihistamines Can’t Touch
Many forms of chronic itch have little to do with histamine. A signaling molecule called IL-31, part of the immune system’s inflammatory toolkit, is a major itch driver in conditions like eczema. Compared to histamine, IL-31 produces a slower-onset itch that builds over hours rather than minutes, which helps explain the persistent, grinding itch that people with eczema describe. IL-31 binds to its own dedicated receptor on sensory nerve fibers, bypassing the histamine pathway entirely.
Proteases, enzymes that break down proteins, are another non-histamine trigger. They activate a receptor called PAR2 on nerve fibers in the skin, and PAR2 activity is elevated in eczema-affected skin specifically. Psoriasis-related itch, by contrast, involves a different molecular profile, with increased activity in cold-sensing and other ion channels. This is why two itchy skin conditions can feel quite different and respond to different treatments.
Common Skin Conditions That Itch
Eczema (atopic dermatitis) is probably the most recognized itchy skin condition. The itch often precedes the visible rash, and scratching damages the skin barrier further, letting in more irritants and allergens, which triggers more itch. This scratch-itch cycle is a defining feature of the disease.
Dry skin (xerosis) is the simplest and most widespread cause of itching. When the outer layer of skin loses moisture, it cracks at a microscopic level, exposing nerve endings and allowing irritants to penetrate more easily. Contact dermatitis, caused by direct exposure to an irritant or allergen like poison ivy, nickel, or certain soaps, triggers a localized immune response that produces intense itching at the site of contact. Fungal infections, psoriasis, and scabies round out the most common dermatological causes.
When Itching Comes From Inside the Body
Generalized itching with no visible rash can be a signal from an internal organ. Liver diseases, particularly conditions that block bile flow, are well-known causes. Primary biliary cirrhosis, hepatitis B and C, and bile duct cancers can all produce widespread itch, likely because substances that normally exit through bile accumulate in the bloodstream and stimulate nerve fibers.
Kidney failure produces itch in roughly 50 to 90% of people on dialysis, though interestingly, it doesn’t occur in acute kidney failure. The mechanism likely involves circulating toxins the kidneys can no longer filter. Thyroid disorders cause itch through different routes: an overactive thyroid increases blood flow and skin temperature, while an underactive thyroid dries the skin. Poorly controlled diabetes can trigger itch that’s often localized to the scalp or genital area, sometimes from associated yeast infections and sometimes from nerve damage. Even iron-deficiency anemia and certain cancers, particularly lymphomas, can present with unexplained itching as an early symptom.
Nerve Damage and “Phantom” Itch
Just as damaged nerves can produce phantom pain, they can produce phantom itch. Neuropathic itch occurs when the nerve fibers or pathways that carry itch signals become injured, causing them to fire spontaneously with no external trigger at all. The sensation can be completely independent of anything happening on the skin’s surface.
Shingles is the most common cause. When the varicella-zoster virus reactivates, it kills a proportion of sensory neurons, and the resulting nerve damage can leave behind chronic post-herpetic itch that persists for months or years. This can be just as disabling as the better-known post-herpetic pain, and the two can occur together or independently. Compressed or pinched spinal nerves from degenerative spine disease cause localized itchy patches on the back (notalgia paresthetica) or arms (brachioradial pruritus), conditions that are often misdiagnosed as simple skin problems because the itch is felt in the skin even though the problem is in the spine.
Cold Weather, Dry Air, and Other Triggers
Low humidity and cold temperatures weaken the skin’s barrier function and make it more reactive to irritants and allergens. In dry conditions, skin cells release pro-inflammatory molecules, and the number of mast cells in the deeper skin layers actually increases, priming the skin to itch more easily. This is why eczema flares spike in winter and why simply moving to a heated, low-humidity indoor environment can trigger itching even in people without a diagnosed skin condition.
Rough textile fibers (especially wool), hot water, and certain laundry detergents physically disrupt the skin barrier or chemically irritate nerve endings. Sweat itself can be a trigger: as it evaporates, it concentrates salts and other compounds on the skin surface that activate itch receptors.
How Stress and Anxiety Amplify Itch
Stress doesn’t just make you more aware of itching. It physically lowers your itch threshold, meaning stimuli that wouldn’t normally bother you start registering as itchy. The mechanism involves stress hormones, particularly corticotropin-releasing factor, which floods brain regions involved in both stress and sensory processing. Over time, chronic stress causes lasting changes in these brain circuits, making them more sensitive to itch signals.
This creates a vicious cycle: chronic itch acts as a chronic stressor, which sensitizes the brain’s anxiety circuits, which amplifies the itch perception, which increases stress. People with eczema and other chronic itch conditions frequently report that emotional stress is their most reliable flare trigger, and research on spinal cord sensitization confirms that itch-signaling pathways can physically rewire themselves to transmit more itch with less provocation.
How Chronic Itch Is Treated Now
For histamine-driven itch, antihistamines remain the first option. But for the many forms of itch that don’t respond to antihistamines, treatment has advanced significantly. Biologic medications that block the IL-4 and IL-13 inflammatory pathways have transformed eczema care by targeting the upstream immune signals that drive both the rash and the itch.
A newer class of oral medications called JAK inhibitors works by blocking the intracellular signaling that multiple itch-promoting cytokines depend on. Selective JAK1 inhibitors have shown higher response rates than broader-acting versions, with some patients experiencing meaningful itch relief within the first week, far faster than biologics, which can take several weeks to reach full effect. For neuropathic itch, treatments overlap with those used for nerve pain, since the underlying problem is misfiring nerves rather than skin inflammation. Moisturizers and barrier-repair creams remain foundational for dry-skin itch, and identifying an underlying systemic cause (liver disease, thyroid dysfunction, kidney failure) can resolve the itch by treating the root problem.